Connect with us

Hi, what are you looking for?

Monday, Mar 27, 2023
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Calgary’s ATMA launches psychedelic-assisted therapy training course for physicians

The program’s creation was inspired by new regulations for psychedelic-assisted therapy in Alberta

ATMA creates one of the first psychedelic training courses for physicians
Photo via ATMA Journey Centers

Calgary-based ATMA Journey Centers has launched one of the first psychedelic training programs for physicians and health professionals in Alberta.

On Tuesday, the psychedelic therapy company said the training course being offered this year is inspired by Alberta’s new legal framework and an inherent need to educate more healthcare professionals on proper protocols for the use of the substances.

The course will cover topics such as ethics, consent, dosage, integration and an overview of the various types of medicine. According to the company, only a handful of physicians and psychiatrists in the country have proper clinical experience working with substances like MDMA or psilocybin.

Read more: ATMA receives Health Canada approval for new psilocybin trial

Read more: Alberta pioneers psychedelic therapy regulations in Canada

ATMA’s chief medical officer says that having an in-depth understanding of psychedelics and their therapeutic effects is of the utmost importance for the role doctors are being requested to play in Alberta’s psychedelic therapy framework.

“There are just a handful of physicians and psychiatrists across Canada that have had clinical experience working with psilocybin or MDMA, medicines which can be night and day from, for instance, ketamine,” said Ravi Bains, ATMA’s Chief Medical Officer.

As of January 16, Alberta adopted a series of regulations, guidelines and rules for providing psychedelic-assisted therapy in the province. Offering therapy involving the use of substances like psilocybin or MDMA will require a license under the province’s Mental Health Services Protection Act.

Administration of psychedelic therapies is now only permitted in medical facilities or clinics in Alberta, with the exception of end-of-life care.

Read more: PharmAla Biotech gets Health Canada approval to export large MDMA shipment to the U.K.

Read more: Apex Labs doses first patient in Veterans take-home psilocybin drug trial

Alberta regulations clearly state the need for education and training of all practitioners involved in the psychedelic-assisted therapy framework, including physicians and psychiatrists, and ATMA is excited to be a top training provider to support this regulatory framework,” said David Harder, Founder of ATMA. 

“We believe physicians and prescribers need a thorough understanding of these medicines as more patients will come to them asking questions and wanting to be referred for these treatments.”

Registration for the Physicians and Prescribers Psychedelic Therapy Training Program is now open with the first course beginning this April. ATMA also says the program is eligible for Continuing Medical Education credits.

Other psychedelic-assisted therapy training programs in Canada are currently being offered by organizations such as TheraPsil and Vancouver Island University.


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Rowan Dunne on Twitter












Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Eight patients sued the government at the end of July last year over what they believe is a violation of constitutional rights


'SANA-013' is a proprietary therapy intended to treat conditions like migraines, episodic cluster headaches and MDD


The state's House of Representatives approved the legislation on Thursday


According to the Athabasca Chipewyan First Nation chief this does not appear to be a simple accident, but a systemic failure of Imperials' tailing...